Ajanta Pharma Limited
AJANTPHARM
Rang in Aktien
#3727
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aktienkurs
$36.09
Marktkapitalisierung
$4.51B
Veränderung (1 Tag)
-0.88%
Veränderung (1 Jahr)
29.78%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Ajanta Pharma Limited (AJANTPHARM)
Anzahl der ausstehenden Aktien zum June 2026: 124.94M
Laut den neuesten Finanzberichten und dem Aktienkurs von Ajanta Pharma Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 124.94M. Am Ende von March 2024 hatte das Unternehmen 125.92M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Ajanta Pharma Limited (AJANTPHARM) von 2005 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 124.94M | -0.19% |
| 2025 | 125.17M | -0.59% |
| 2024 | 125.92M | -1.72% |
| 2023 | 128.12M | -1.19% |
| 2022 | 129.66M | -0.73% |
| 2021 | 130.62M | -0.21% |
| 2020 | 130.89M | -0.84% |
| 2019 | 132.00M | 0.00% |
| 2018 | 132.00M | 0.00% |
| 2017 | 132.01M | 0.01% |
| 2016 | 131.99M | 0.07% |
| 2015 | 131.91M | 0.07% |
| 2014 | 131.81M | 0.04% |
| 2013 | 131.75M | 0.02% |
| 2012 | 131.72M | 0.00% |
| 2011 | 131.72M | 0.00% |
| 2010 | 131.72M | 0.00% |
| 2009 | 131.72M | 0.00% |
| 2008 | 131.72M | 0.00% |
| 2007 | 131.72M | 0.00% |
| 2006 | 131.72M | 0.00% |
| 2005 | 131.72M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,820.46% |
IN
|
